Comparison of Hepatocellular Markers for Diagnosis of Poorly-Differentiated Hepatocellular Carcinoma: High Sensitivity with Combined Use of Arginase-1 and Glypican-3

被引：0
|
作者：
Phillips, D. G. K.
Jain, D.
Torbenson, M.
Wu, T-T
Yeh, M. M. C.
Kakar, S.
机构：
[1] Univ Calif San Francisco, San Francisco, CA 94143 USA
[2] Yale New Haven Med Ctr, New Haven, CT 06504 USA
[3] Johns Hopkins Univ Hosp, Baltimore, MD 21287 USA
[4] Mayo Clin, Rochester, MN USA
[5] Univ Washington, Seattle, WA 98195 USA
来源：
LABORATORY INVESTIGATION | 2012年 / 92卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1760
引用
收藏
页码：422A / 422A
页数：1
相关论文
共 50 条
  • [31] Multiparametric MRI combined with clinical factors to predict glypican-3 expression of hepatocellular carcinoma
    Liu, Peijun
    Li, Weiqiu
    Qiu, Ganbin
    Chen, Jincan
    Liu, Yonghui
    Wen, Zhongyan
    Liang, Mei
    Zhao, Yue
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [32] Utility of HSP70, Glutamine Synthethase and Glypican-3 in Distinguishing Hepatocellular Adenoma from Well-Differentiated Hepatocellular Carcinoma
    Nguyen, T. B.
    Kakar, S.
    LABORATORY INVESTIGATION, 2012, 92 : 420A - 420A
  • [33] Utility of HSP70, Glutamine Synthethase and Glypican-3 in Distinguishing Hepatocellular Adenoma from Well-Differentiated Hepatocellular Carcinoma
    Nguyen, T. B.
    Kakar, S.
    MODERN PATHOLOGY, 2012, 25 : 420A - 420A
  • [34] Utility and limitations of glypican-3 expression for the diagnosis of hepatocellular carcinoma at both ends of the differentiation spectrum
    Shafizadeh, Nafis
    Ferrell, Linda D.
    Kakar, Sanjay
    MODERN PATHOLOGY, 2008, 21 (08) : 1011 - 1018
  • [35] Review Article Alpha-fetoprotein, glypican-3, and kininogen-1 as biomarkers for the diagnosis of hepatocellular carcinoma
    Dominguez-Lazcano, Diana Gabriela
    Simon-Lara, Ingrid
    Morales-Romero, Jaime
    Vasquez-Garzo, Veronica Rocio
    Arroyo-Helguera, Omar Elind
    Lopez-Vazquez, Julieta
    Campos-Parra, Alma D.
    Hernandez-Nopaltecatl, Brayan
    Rivera-Hernandez, Ximena Andrea
    Quintana, Sofia
    Garcia-Roman, Rebeca
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2024, 17 (11): : 383 - 395
  • [36] Exploring Glypican-3 as a Molecular Target in Hepatocellular Carcinoma: Perspectives on Diagnosis and Precision Immunotherapy Strategies
    Tojjari, Alireza
    Hafez, Abdelrahman H.
    Saeed, Ali
    Singh, Meghana
    Saeed, Anwaar
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2024, 29 (07):
  • [37] PROSPECTIVE VALIDATION OF IMMUNOHISTOLOGICAL STAIN FOR GLYPICAN-3 (GPC-3) IN THE EARLY DIAGNOSIS OF HEPATOCELLULAR CARCINOMA
    Sangiovanni, Angelo
    Arosio, Eliana
    Balestrieri, Maria Rita
    Ronchi, Guido
    Manini, Matteo A.
    Iavarone, Massimo
    Romeo, Raffaella
    Colombo, Massimo
    HEPATOLOGY, 2008, 48 (04) : 949A - 949A
  • [38] HCRP1, ID4 and Glypican-3: an optimal panel of biomarkers for diagnosis of hepatocellular carcinoma
    Ge, Shujian
    Wang, Dan
    Lv, Beibei
    Yang, Shuping
    Liu, Chunmei
    Xu, Bin
    Zhao, Chunming
    Qin, Yejun
    Xu, Jiawen
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2018, 11 (12): : 5774 - 5782
  • [39] Preliminary study of three tumor markers for hepatocellular carcinoma: AFP, AFP-L3, and Glypican-3
    Li, H.
    Qu, K. Z.
    Ner, R. M.
    Sferruzza, A. D.
    Bender, R. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [40] A Novel Peptide Binder to Glypican-3 Demonstrates High Specificity as a Theranostic Agent for Hepatocellular Carcinoma
    Bal, Chandraskhar
    Ballal, Sanjana
    Kallur, Kumarswamy
    Yuan, Ye
    Rearden, Jessica
    Shah, Kathryn
    Lorenz, Charlotte
    Moran, Susan
    Song, Ken
    Sen, Ishita
    Thakral, Parul
    Malik, Dharmender
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65
12345